BNP Paribas Asset Management’s AstraZeneca AZN Stock Holding History

BNP Paribas Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.48B	Buy	7,624,427 +7,405,435	+3,382%	+$1.43B	1.72%	7
2025 Q4	$40.3M	Buy	+218,992	New	+$38.4M	0.05%	354
2021 Q4	–	Sell	-5,049	Closed	-$606K	–	921
2021 Q3	$606K	Buy	+5,049	New	+$588K	﹤0.01%	792
2016 Q4	–	Sell	-35,973	Closed	-$2.36M	–	984
2016 Q3	$2.36M	Buy	+35,973	New	+$2.35M	0.02%	676

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

BNP Paribas Asset Management's AZN Position: Q1 2026 in Review

BNP Paribas Asset Management increased its AstraZeneca (AZN) stake by 3,382% in Q1 2026, buying an estimated $1.43B and bringing the position to 7,624,427 shares worth $1.48B. The position accounts for 1.72% of the portfolio, ranked #7.

BNP Paribas Asset Management first reported a position in AZN in Q3 2016 and has held it in 4 quarters since. 1,382 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

BNP Paribas Asset Management held 7,624,427 shares of AstraZeneca worth $1.48B as of Q1 2026.
BNP Paribas Asset Management bought 7,405,435 AstraZeneca shares in Q1 2026, an estimated $1.43B.
AstraZeneca made up 1.72% of BNP Paribas Asset Management's portfolio in Q1 2026, its #7 holding.
BNP Paribas Asset Management first reported a position in AstraZeneca in Q3 2016 and has held it in 4 quarters since.
1,382 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.